Pourhassan, H., Zhang, J., Stock, W., Geyer, M., Advani, A., Park, J., Curran, E., Tiemann, K., Agrawal, V., Koller, P., Tinajero, J., Kovacsovics, T., Stein, A. S., Marcucci, G., Stricherz, M., Faderl, S., Pullarkat, V., Aldoss, I. (2025). A phase 2 study evaluating the safety and efficacy of first line asparaginase recombinant erwinia asparaginase (Rylaze) during pediatric-inspired regimen in high-risk adults with newly diagnosed ALL or lbl. Blood. https://doi.org/10.1182/blood-2025-8233